Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Soroka University Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Ben-Gurion University of the Negev
Information provided by:
Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT01165918
First received: July 6, 2010
Last updated: July 18, 2010
Last verified: June 2010
  Purpose

The purpose of this study is

  1. To generate human embryonic stem cells lines (hESC) lines
  2. Study of the factors that contribute to differentiation towards germ cell.

Condition
Normal Healthy Embryos

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Basic Research. Unveiling Factors That Contribute to Germ Cell Differentiation

Further study details as provided by Soroka University Medical Center:

Primary Outcome Measures:
  • New hESC [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Donated embryos will be used for derivation of the Es cells


Secondary Outcome Measures:
  • Factors that contribute to germ cells differentiation [ Time Frame: 4 years ] [ Designated as safety issue: No ]
    We shall employ the knowledge from a study of sperm differentiation in mice to instruct the differentiation of ES cells towards germ cells


Estimated Enrollment: 50
Study Start Date: October 2010
Groups/Cohorts
Donated embryos

  Eligibility

Ages Eligible for Study:   up to 4 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

any donated embryo

Criteria

Inclusion Criteria:

  • any donated embryos

Exclusion Criteria:

  • not relevant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01165918

Contacts
Contact: Eitan Lunenfeld, MD and Prof. - 972-8-6460058 lunenfld@bgumail.bgu.ac.il
Contact: Rivka Ofir 97286477272 rivir@bgu.ac.il

Locations
Israel
Soroka medical center Not yet recruiting
Beer Sheva, Israel, 84101
Contact: Rivka Ofir, PhD    972 8 6477272    rivir@bgu.ac.il   
Sub-Investigator: Rivka Ofir, PhD         
Sponsors and Collaborators
Soroka University Medical Center
Ben-Gurion University of the Negev
  More Information

No publications provided

Responsible Party: Dr. Eitan Lunenfeld, Soroka Medical Center
ClinicalTrials.gov Identifier: NCT01165918     History of Changes
Other Study ID Numbers: Sor491210CTIL
Study First Received: July 6, 2010
Last Updated: July 18, 2010
Health Authority: Israel:Clalit Health Service

ClinicalTrials.gov processed this record on April 15, 2014